已收录 273175 条政策
 政策提纲
  • 暂无提纲
Hypolipidemic Effect of Ethyl all-cis-5, 8, 11, 14, 17-Icosapentaenoate (EPA-E) in Rats
[摘要] References(27)Cited-By(15)We examined the effect of ethyl all-cis-5, 8, 11, 14, 17-icosapentaenoate (EPA-E) with high purity on circulating lipids in rats under several experimental conditions. In normolipidemic rats, EPA-E decreased the lipids in a dose-dependent manner. Clofibrate (100 mg/kg/day) was more potent in lowering the lipids than EPA-E (1000 mg/kg/day). In high cholesterol diet-fed rats, EPA-E (300 mg/kg/day) decreased the total cholesterol. However, clofibrate (300 mg/kg/day) had little effect on the total cholesterol. In hypertriglycemic rats induced by corn oil, EPA-E (300 mg/kg/day) or clofibrate (100 mg/kg/day) reduced the rise of triglycerides. EPA-E (300 mg/kg/day), clinofibrate (100 mg/kg/day) or clofibrate (300 mg/kg/day) caused a significant reduction in the lipids induced by the injection of Triton WR-1339. Furthermore, EPA-E (300 mg/kg/day) or clinofibrate (100 mg/kg/day) decreased the elevation of lipids produced by feeding the rats a casein-rich diet. These results show that EPA-E possesses potent inhibitory activity on experimental hyperlipidemia induced either exogenously or endogenously.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 药理学
[关键词] EPA-E (ethyl all-cis-5;8;11;14;17-icosapentaenoate);Hypolipidemic action;Clofibrate [时效性] 
   浏览次数:19      统一登录查看全文      激活码登录查看全文